Results 61 to 70 of about 30,750 (313)

IMPACTO DA COVID-19 NA INCIDÊNCIA, DISTRIBUIÇÃO DE ESPÉCIES E NO PROGNÓSTICO DAS INFECÇÕES DE CORRENTE SANGUÍNEA POR CANDIDA

open access: yesBrazilian Journal of Infectious Diseases, 2022
A Covid-19 está associada a infecções fúngicas invasivas (IFI) principalmente por Aspergillus e agentes da mucormicose. O aumento de infecção de corrente sanguínea por Candida (candidemia) também vem sendo foco de atenção.
Marcia Garnica   +4 more
doaj   +1 more source

Machine-learning based prediction and analysis of prognostic risk factors in patients with candidemia and bacteraemia: a 5-year analysis [PDF]

open access: yesPeerJ, 2022
Bacteraemia has attracted great attention owing to its serious outcomes, including deterioration of the primary disease, infection, severe sepsis, overwhelming septic shock or even death.
Yali Gao   +11 more
doaj   +2 more sources

Candidemia Among Coronavirus Disease 2019 Patients in Turkey Admitted to Intensive Care Units: A Retrospective Multicenter Study

open access: yesOpen Forum Infectious Diseases, 2022
Background We evaluated the epidemiology of candidemia among coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs). Methods We conducted a retrospective multicenter study in Turkey between April and December 2020.
A. Arastehfar   +14 more
semanticscholar   +1 more source

Epidemiology of and risk factors for neonatal candidemia at a tertiary care hospital in western China

open access: yesBMC Infectious Diseases, 2016
Background The prevalence and clinical characteristics of neonatal candidemia are poorly understood in western China. The aim of our study was to evaluate the epidemiological features of neonatal candidemia in the Liuzhou Maternity and Child Healthcare ...
Jichang Chen   +6 more
doaj   +1 more source

First hospital outbreak of the globally emerging Candida auris in a European hospital [PDF]

open access: yes, 2016
Background: Candida auris is a globally emerging multidrug resistant fungal pathogen causing nosocomial transmission. We report an ongoing outbreak of C. auris in a London cardio-thoracic center between April 2015 and July 2016.
Abdolrasouli, A   +11 more
core   +2 more sources

Distribution, trends, and antifungal susceptibility of Candida species causing candidemia in Japan, 2010–2019: A retrospective observational study based on national surveillance data

open access: yesMedical Mycology, 2022
The increasing incidence of candidemia and the emergence of drug-resistant Candida species are major concerns worldwide. Therefore, long-term surveillance studies are required.
T. Kajihara   +8 more
semanticscholar   +1 more source

Incidence and risk factors for COVID‐19 associated candidemia (CAC) in ICU patients

open access: yesMycoses (Berlin), 2022
Critically ill COVID‐19 patients have a high risk for the development of candidemia due to being exposed to both well‐defined classical risk factors and COVID‐19‐specific risk factors in ICU.
B. Kayaaslan   +12 more
semanticscholar   +1 more source

Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study.

open access: yesJournal of Infectious Diseases, 2020
BACKGROUND Candidemia is the most common, serious fungal infection and Candida antifungal resistance is a challenge. We report recent surveillance of candidemia in China. METHODS The study encompassed 77 Chinese hospitals over 3 years.
M. Xiao   +19 more
semanticscholar   +1 more source

Epidemiologic features, clinical characteristics, and predictors of mortality in patients with candidemia in Alameda County, California; a 2017–2020 retrospective analysis

open access: yesBMC Infectious Diseases, 2022
Background Bloodstream infections caused by Candida species are responsible for significant morbidity and mortality worldwide, with an ever-changing epidemiology.
Didien Meyahnwi   +2 more
semanticscholar   +1 more source

Changes in the utilization patterns of antifungal agents, medical cost and clinical outcomes of candidemia from the health-care benefit expansion to include newer antifungal agents

open access: yesInternational Journal of Infectious Diseases, 2019
Objectives: In 2014, South Korea expanded its national health insurance coverage to include newer antifungal agents, such as echinocandins. This study aimed to investigate the effects of policy change on the prescription patterns of antifungals, medical ...
Heun Choi   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy